Editor’s Choice for May 2018
Published: 21 May 2018
Views: 1858
Prof Gordon McVie - Founding Editor, ecancer
- Categories:
- Brain & nervous system
- Breast
- Melanoma & skin
- Neuroendocrine
- Ovary & gynaecology
- Prostate & urology
- Nutrition & wellbeing
- Patient empowerment
- Personalised medicine
- Psychosocial
- Care
- Economics
- Low-middle income
- Medicines
- Organisation of cancer
- Prevention
- R&D
- Regulatory
- Science domains
- Social determinants
- Technology & innovation
- Training & development
- Bioinformatics
- Biology
- Biomarkers
- Causes of cancer
- Control, survivorships & outcomes
- Detection, diagnosis & prognosis
- Diagnostics
- Epidemiology & prevention
- Antibodies & immunotherapy
- Cell therapy & stem cells
- Complications
- Cytotoxics
- Drug development
- Hormones/endocrine
- Radiotherapy
- Supportive care
- Surgery
- Targeted molecules
- Vaccines & virus
Related Videos
Updates on criteria for patient selection and surgical management in advanced ov...
Prof Pedro Ramirez - MD Anderson Cancer Center, Houston, USA
20 Jan 2021
What is global oncology and what is the presence of global oncology in Europe
Prof Cristina Stefan - Institute of Oncology 'Prof Dr Alexandru Trestioreanu', B...
12 Oct 2020
ESMO 2020 melanoma roundup
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
28 Sep 2020
PARP inhibitors and their evolving role for the treatment of prostate cancer
Dr Neal Shore, Dr Neeraj Agarwal, Dr Elena Castro and Dr Kim Chi
24 Sep 2020
Future perspective of CDH1 mutation in gastric and breast cancers
Dr. Giovanni Corso - University of Milan, Italy, Meeting president
22 Jul 2020
IMvigor130: Atezolizumab with or without chemotherapy in metastatic urothelial c...
Prof Matthew Galsky - The Mount Sinai Hospital, New York, USA
30 Jun 2020
Advances in breast cancer treatment over the last 20 years
Dr Philip Poortmans - Institut Curie, Paris, France
27 Jan 2020
Melanoma highlights from ESMO 2019
Dr Teresa Amaral - University Hospital Tübingen, Tübingen, Germany
30 Sep 2019
The global program of the American Cancer Society
Dr Meg O'Brien - American Cancer Society, Atlanta, USA
5 Jun 2019
